$CRSP CRISPR Therapeutics AG Insider Trading Week 23/2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in CRISPR Therapeutics AG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in CRISPR Therapeutics AG in week 23/2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Behbahani Ali | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Behbahani Ali | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 59.31 | 32,000 | 1,897,920 | 32,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | KASINGER JAMES R. | General Counsel and ... | Option Exercise | A | 59.31 | 32,000 | 1,897,920 | 32,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 59.31 | 30,000 | 1,779,300 | 30,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Bolzon Bradley J PhD | Director | Option Exercise | A | 59.31 | 30,000 | 1,779,300 | 30,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | A | 59.31 | 30,000 | 1,779,300 | 30,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Ho Tony W | See Remarks | Option Exercise | A | 59.31 | 43,000 | 2,550,330 | 43,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Woiwode Thomas | Director | Option Exercise | A | 59.31 | 30,000 | 1,779,300 | 30,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 59.31 | 20,760 | 1,231,276 | 20,760 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | A | 59.31 | 109,000 | 6,464,790 | 109,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Ho Tony W | See Remarks | Option Exercise | A | 59.31 | 43,000 | 2,550,330 | 43,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | TOMSICEK MICHAEL JOHN | Chief Financial Off ... | Option Exercise | A | 59.31 | 20,760 | 1,231,276 | 20,760 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | Kulkarni Samarth | Chief Executive Off ... | Option Exercise | A | 59.31 | 109,000 | 6,464,790 | 109,000 | |
Jun 15 2018 | CRSP | CRISPR Therapeutic ... | CAGNONI PABLO J | Director | Option Exercise | A | 59.31 | 15,000 | 889,650 | 15,000 |